News Article | May 23, 2017
The Early Childhood Center at B'nai Torah Congregation in Boca Raton will put a sunny spin on summer school by offering VPK (Voluntary PreK) alongside their annual Camp Keshet - Summer Camp Program. -- The NAYCE accredited Ruth and Edward Taubman Early Childhood Center located at B'nai Torah is not just the only VPK program in Palm Beach County offered during the summer, it's also cleverly integrated into the congregation's super popular summer camp program.Voluntary Prekindergarten or VPK gives children a jump start by preparing them for school and enhancing their pre-reading, pre-math, language and social skills. By developing the skills children need to become strong readers and students at an early age, children are more likely to be successful in school. But what kid wants to go to school during the summer? The ECC at B'nai Torah figured out how to make summer time learning into summertime fun by offering some of the same activities their campers are enjoying.The approximately 72 students enrolled in the ECC's VPK summer program will experience an interactive Mobile Planetarium, the only on-site STEM and Coding Center in Palm Beach County, a petting zoo, fun-filled olympic-style outdoor activities, and the latest style in learning - the progressive Reggio Emilia Art Program. "Each year we open our doors to all children, not just those whose families are members of our congregation,"mpentions Nancy Goldstein, Director of the Ruth and Edward Taubman Early Childhood Center. " The key to a successful summer VPK program is to not only offer the highest caliber of learning, but to also ensure children have the fun summer they need and deserve," Nancy adds."Something else that speaks volumes about our summer camp and VPK program is the fact that those who graduated from our ECC and/or attended our summer camp program are now returning more and more as teachers, CIT's, and senior and junior counselors. The have come full circle by coming back to the place that resonated with them in a positive way as children." Some of the Summer Camp activities offered at our ECC that make us unique include weekly horseback riding with a "Giddy-up Shabbat," off-site visits to a water park and swimming, juggling class, music, dancing and more.
News Article | May 11, 2017
TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE MKT: OGEN), a clinical stage biotechnology company, today announced that it has entered into a securities purchase agreement with three accredited investors, to purchase up to $3.0 million of Series A convertible preferred stock at a price of $0.25 per share (the “Preferred Stock Financing”). Concurrently with the Preferred Stock Financing, the Company also entered into a Note Purchase Agreement with Intrexon Corporation (“Intrexon”) pursuant to which the Company issued a $2.4 million unsecured non-convertible promissory note to Intrexon (the “Intrexon Note”) and amended the first milestone in its oral mucositis Exclusive Channel Collaboration Agreement (“ECC”) with Intrexon. Dr. Alan Joslyn, the Company’s Chief Executive Officer stated, “We are pleased with the financial commitment that our investors and Intrexon have shown to the Company’s technologies through these financings. The proceeds from the stock offering combined with the loan from Intrexon will enable us to continue advancing our promising biotherapeutic candidate AG013 toward the clinic for the treatment of oral mucositis.” The sale of the Series A Preferred Stock will take place in two separate closings and at the first closing, which occurred on May 10, 2017, the Company received gross proceeds of approximately $1.302 million. Upon the successful completion of the second closing, the Company expects to receive the balance of the Preferred Stock Financing of $1.698 million. The shares of Series A Preferred Stock are convertible at any time into shares of the Company’s Common Stock, based on an initial fixed conversion price of $0.25 per share. In addition, the Company issued warrants to purchase an aggregate of 4,621,037 shares of Common Stock at the first closing and will be obligated to issue additional warrants to purchase an aggregate of 6,024,124 shares of Common Stock at the second closing. The Warrants have a term of seven years from the date of issuance, are non-exercisable until 6 months after issuance, and have an exercise price of $0.31 per share. The second closing is contingent upon the Company receiving shareholder approval required by the NYSE MKT listing rules. The Company has entered into voting agreements with the Koski Family Limited Partnership and Intrexon Corporation, holders of a majority of our common stock, pursuant to which they have agreed to vote all of their shares of common stock for approval. Proceeds from the Preferred Stock Financing (including the exercise of any warrants for cash) will be used for general corporate purposes, including working capital. The Intrexon Note matures in two (2) years and has a simple interest rate of 12% per annum. Proceeds from the Intrexon Note will be used to fund the Company’s AG013 research and clinical trials. In addition to, and as part of the Intrexon Note, the Company and Intrexon agreed to amend the first milestone payment on the ECC from a $2.0 million payment upon first dosing of a patient to a $3.0 million payment upon the earlier of (a) dosing of the last patient, in a phase II clinical trial, and (b) the twenty four (24) month anniversary of the dosing of the first patient in the phase II clinical trial. The Preferred Stock, Warrants and Note were offered and sold in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. The Preferred Stock, the Note, the Warrants and the Common Stock issuable upon the conversion of the Preferred Stock and the exercise of the Warrants have not been registered under the Securities Act and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Dawson James Securities, Inc. served as financial advisor to the Company. We are focused on becoming a world leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics, Inc. has established two exclusive worldwide channel collaborations with Intrexon Corporation, a synthetic biology company. The collaborations allow Oragenics access to Intrexon's proprietary technologies toward the goal of accelerating the development of much needed new antibiotics that can work against resistant strains of bacteria and the development of biotherapeutics for oral mucositis and other diseases and conditions of the oral cavity, throat, and esophagus. For more information about Oragenics, please visit www.oragenics.com. Safe Harbor Statement: Under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements that reflect management’s current views with respect to future events and performance. These forward-looking statements are based on management’s beliefs and assumptions and information currently available. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project” and similar expressions that do not relate solely to historical matters identify forward-looking statements. Investors should be cautious in relying on forward-looking statements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in any such forward-looking statements. These factors include, but are not limited to, our ability to consummate the second closing, our ability to raise capital in the future, our current need for financing to meet our operational needs and to be able to move our product candidates forward through pre-clinical and clinical development, our inability to obtain sufficient financing to conduct our business; any inability to obtain or delays in the Food and Drug Administration approval for future clinical studies and testing, the future success of our studies and testing and any inability to also achieve favorable results in human studies, our ability to successfully develop and commercialize products, the financial resources available to us to continue research and development, any inability to regain compliance with the NYSE MKT continued listing requirements and those other factors described in our filings with the U.S. Securities and Exchange Commission. Any responsibility to update forward-looking statements is expressly disclaimed.
News Article | May 9, 2017
GREENWICH, Conn.--(BUSINESS WIRE)--Eagle Point Credit Company Inc. (the “Company”) (NYSE:ECC, NYSE:ECCA, NYSE:ECCB, NYSE:ECCZ), today announced that it plans to report financial results for the quarter ended March 31, 2017 prior to the opening of the financial markets on Tuesday, May 23, 2017. The Company will discuss its financial results on a conference call on that day at 10:00 a.m. (Eastern Time). Thomas P. Majewski, Chief Executive Officer, will host the call along with Kenneth P. Onorio, Chief Financial Officer. All interested parties are welcome to participate in the conference call via one of the following methods: The Company is a non-diversified, closed-end management investment company. The Company’s investment objectives are to generate high current income and capital appreciation primarily through investment in equity and junior debt tranches of collateralized loan obligations. The Company is externally managed and advised by Eagle Point Credit Management LLC. The principals of Eagle Point Credit Management LLC are Thomas P. Majewski, Daniel W. Ko and Daniel M. Spinner. The Company makes certain unaudited portfolio information available each month on its website in addition to making certain other unaudited financial information available on its website (www.eaglepointcreditcompany.com). This information includes (1) an estimated range of the Company’s net investment income (“NII”) and realized capital gains or losses per weighted average share of common stock for each calendar quarter end, generally made available within the first fifteen days after the applicable calendar month end, (2) an estimated range of the Company’s NAV per share of common stock for the prior month end and certain additional portfolio-level information, generally made available within the first fifteen days after the applicable calendar month end, and (3) during the latter part of each month, an updated estimate of NAV, if applicable, and, with respect to each calendar quarter end, an updated estimate of the Company’s NII and realized capital gains or losses for the applicable quarter, if available. This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company’s filings with the U.S. Securities and Exchange Commission. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.
News Article | May 11, 2017
SEATTLE, WA--(Marketwired - May 11, 2017) - Avalara, Inc., a leading provider of cloud-based tax compliance automation for businesses of all sizes, today announced it is certified for SAP's ERP Central Component (ECC) solution for North America. The certified integration allows SAP customers to deploy a reliable, complete tax automation solution within their existing ERP system. As a result of this partnership, SAP ECC customers now have access to AvaTax™, Avalara's cloud-based solution, which automatically calculates applicable sales and use taxes, fees, and surcharges for every billing line item, in real-time. The automated solution eliminates the tedious work and complexity of managing the changing tax landscape. "Our established relationship with SAP has allowed its customers access to Avalara's tax engine across a variety of products, and we are proud to expand support into its core ERP offering," said Marshal Kushniruk, executive vice president of global business development for Avalara. "Implementing the Avalara AvaTax solution for SAP ECC was a major win for us, both for the business and IT groups. Being in the building materials and construction industry, we are often delivering goods to locations that do not yet have a valid physical address. The complexity of determining sales tax was enormous prior to integrating AvaTax," said Mike Bowen, Director of Business Process and Architecture for CalPortland Company. "Moving from an on-premise tax system to a cloud-based solution greatly reduced the burden on IT to maintain servers, install system updates and test tax rate changes." The ECC certification further expands Avalara's integrations within the SAP ecosystem, and complements Avalara's existing integration partnerships with Hybris, SAP's leading ecommerce platform, SAP Business One, and with Implico, a leading SAP implementation partner in the oil and gas industry. Avalara is sponsoring SAP Sapphire 2017, which takes place May 16-18 in Orlando. Four joint customers of Avalara and SAP will be hosting a panel discussion in Avalara's booth to discuss how automating tax compliance has changed their businesses. Hosted at the Avalara booth, #1343, the talk with Radisys, CalPortland, TomTom and AntonPaar will be held at the following times: The SAP ECC integration for Avalara was developed by DuCharme, McMillen & Associates (DMA), a corporate tax consultancy specializing in six key areas including tax technology, property tax, sales/use & commodity tax, state income & franchise tax, crown royalties, and unclaimed property tax. For more than a decade, Avalara has pioneered innovations in tax compliance for businesses of all sizes. Today, Avalara offers hundreds of pre-built connectors into leading accounting, ERP, ecommerce and other business applications making the integration of tax and compliance solutions easy for customers. About Avalara Avalara helps businesses of all sizes achieve compliance with transactional taxes, including sales and use, VAT, excise, communications, and other tax types. The company delivers comprehensive, automated, cloud-based solutions that are designed to be fast, accurate, and easy to use. Avalara's Compliance Cloud™ platform helps customers manage complicated and burdensome tax compliance obligations imposed by state, local, and other taxing authorities throughout the world. Avalara offers more than 550 pre-built connectors into leading accounting, ERP, ecommerce and other business applications making the integration of tax and compliance solutions easy for customers. Each year, the company processes billions of indirect tax transactions for customers and users, files more than a million tax returns and other compliance documents. A privately held company, Avalara's venture capital investors include Sageview Capital, Battery Ventures, Warburg Pincus, Technology Crossover Ventures, Arthur Ventures, and other institutional and individual investors. Avalara's headquarters are in Seattle and it has offices across the U.S. and in the U.K., Belgium, Brazil, and India. More information at www.avalara.com About DuCharme, McMillen & Associates (DMA) DMA focuses on assisting Canadian and United States clients with their corporate tax challenges. During the last 10 years, DMA has built a very robust Tax Technology practice focused on corporate tax technology and, specifically, transaction taxation. For more information, please visit www.DMAinc.com. SAP, PartnerEdge and all SAP logos are trademarks or registered trademarks of SAP SE in Germany and in several other countries. All other product and service names mentioned herein are the trademarks of their respective owners.
News Article | May 15, 2017
Kellton Tech, a global leader in digital transformation and among SAP’s top value-added partners, announces the completion of a video series project in collaboration with SAP. The video series features a step-by-step guide to S/4 HANA migration,from SAP ECC to S/4HANA 1610. Kellton Tech emerged as a natural partner for this project, as it was one of the first companies to implement SAP S/4 HANA when it was introduced to the market in 2015. As a part of the elite group of top 3% of SAP partners in North America to have successfully earned the recertification of its SAP Partner Center of Expertise (PCoE), Kellton Tech is uniquely positioned to help its customers plan and execute their business transformation. Kellton Tech will be showcasing these capabilities at SAPPHIRE NOW® and ASUG Annual Conference being held on May 16–18 in Orlando, Florida, at booth #787.Kellton Tech will presentits expertise in SAP’s most innovative solutions and platforms including SAP HANA & SAP S/4HANA Migrations & Upgrades, Digital Transformation with SAP Hybris, Fiori, SAP Cloud Solutions, Business Objects and more. Attendees will have the opportunity to engage with Kellton Tech experts and experience its interactive demo environment. “Our engagement in this prestigious project is a testimony to our cutting-edge expertise in SAP. Kellton Tech’s association with SAP is marked with pioneering innovation. We take pride in successfully harnessing the power of SAP to help translate our customer’s vision into reality,” said Prasad Bandari, Head – SAPBU, Kellton Tech. SAPPHIRE NOW® and ASUG Annual Conference is the world’s premier business technology event and largest SAP customer-run conference, offering attendees the opportunity to learn and network with customers, SAP executives, partners and experts across the entire SAP ecosystem. Kellton Tech will also be hosting a private cocktail party at Tin Roof- Orlando, on Wednesday, May 17th from 6:00 – 8:00 PM EST. Attendance is limited. Stop by booth #787 for more details. *To schedule a 1:1 session with its subject matter experts,please visit: https://www.kelltontech.com/kellton-tech-sponsors-sap-sapphire-now-and-asug-annual-conference-orlando About Kellton Tech: Kellton Tech is a global force in digital transformation and enterprise solutions, offering end-to-end SAP solutions, strategic technology consulting and product development services in Social, Mobile, Analytics, Cloud, S/4HANA, Hybris, IoT and Artificial Intelligence.With extensive local customer experience, the Kellton Tech team delivers cross-functional and in-depth industry and technical knowledge to every business challenge. Kellton Tech creates infinite possibilities with technology, allowing customers to revolutionize the way they operate. SAP, SAPPHIRE NOW and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE (or an SAP affiliate company) in Germany and other countries. See http://www.sap.com/corporate-en/legal/copyright/index.epx for additional trademark information and notices. All other product and service names mentioned are the trademarks of their respective companies. For press inquiries and more information contact: Prasad Bandari, Phone# 1-804-502-2660, email: prasad.bandari(at)kelltontech(dot)com
News Article | May 11, 2017
As the first enterprise-ready, ARM-based servers get nearer to release more details are emerging on what these energy-sipping systems will be capable of. The upcoming 64-bit machines are being designed to tackle a far broader range of tasks than the few 32-bit ARM-based servers tested out by a handful of companies this year. Rather than just web serving, these systems are being built to also power data analytics on Hadoop clusters, fetch and put data in NoSQL data stores, streaming media and high-performance computing, sharing processing duties with GPUs, FPGAs or ASICs. Jobs like these can be split into computationally light workloads and processed in parallel by clusters of thousands of wimpy core processors. These dense clusters of low-power servers can handle these parallelisable tasks more efficiently than smaller number of powerful chips, delivering better performance per watt and per square foot of datacentre space, important measures for driving down the cost of running a large server estate. Hence the interest in taking small, energy thrifty ARM-based chipsets, today more commonly found in mobile phones and tablets, and using them in tightly, packed server clusters. A fair proportion of the software needed to handle these web serving, data analytics, streaming media and other jobs are on track to be ready for production use on ARM-based servers. But what about the hardware? Powering these servers will be chipsets from a range of companies - but major players in the nascent ARM-based server space will be likely be Applied Micro with its X-Gene boards and AMD, which is branching out beyond x86 with its Opteron A1100 processor. These forthcoming chips are based on the ARM v8 architecture, which introduces support for features considered critical by business. Not only is v8 the first ARM architecture to support 64-bit cores, it also brings additional enterprise-class features, such as error-correcting code (ECC) memory. The companies behind these server chipsets were at the Hot Chips conference in Cupertino this week to detail the capabilities of their chips and the servers they will power. Three generations of X-Gene system on a chips are planned. The first to hit the market in servers will be the X-Gene1 processor, is expected to be available in production systems this Autumn. The X-Gene processor is already being tested in HP Moonshot servers, has been demoed in HPC and enterprise-targeted systems from Eurotech, E4 and Mitac. Its successor, the X-Gene 2, is available for sampling now and X-Gene 3 is due to be released for sampling in 2015. The X-Gene 1 has eight cores running at 2.4 GHz. It is made to a 40nm process - the smaller the process the more transistors can be crammed onto the chips' surface, allowing for better processing power per watt. The chip's superscalar architecture allows it to handle more than one instruction per processor cycle, with a four-instruction wide processing pipeline that is capable of out-of-order execution, an optimisation that reduces delays in handling instructions. Applied Micro say the chip can handle "more than 100 instructions in flight". Each pair of processor cores shares L1 instruction and data cache, as well as L2 cache. Connected to the cores via a network link that keeps data coherent between caches is 8MB of L3 cache and two dual-channel DDR3 memory controllers. The chipset can support up to 128GB of DDR memory capable of 1,600 MT/s. The chipset integrates networking hardware, removing the need for discrete cards, such as I/O controller hub, NIC and baseboard management controller - reducing additional cost and power draw. For I/O the chipset supports four 10 gigabit Ethernet connections and six PCI-E 3.0 slot, as well as multiple Sata 3 ports. Future releases of the X-Gene will bring further performance improvements and allow servers based on the board to tackle workloads where low application latency is necessary. The X-Gene 2 will add RDMA over Converged Ethernet, or RoCE. RoCE is important feature in distributed systems as it reduces latency between servers in the cluster. This feature allows one server node in an X-Gene cluster to transfer data directly to and from memory of another node over 10 Gbps Ethernet, reducing the work carried out by each node's CPU and improving data transfer speed. Using Roce the X-Gene 2 has shown itself capable of reducing application latency to about 5 microseconds, up to ten times faster than the X-Gene 1, according to Applied Micro. X-Gene 2 will be made to a 28nm process, have up to 16 cores clocked at a maximum of 2.8 GHz and support four channels of memory. Architectural changes will be made to the processor core to boost performance. What is important for the types of workloads suited to being handled in parallel on a cluster of low-energy servers - the likes of web front ends, search engines, NoSQL data stores, data analytics work like Hadoop, and media serving - are factors beyond clock speed. Applied Micro believes the X-Gene delivers on core metrics for these workloads, such as instruction issue width, the number of tiers in the processor cache hierarchy, the size of the cache per CPU and the memory bandwidth of the processor. The graph shows how the X-Gene 2 beats compares to competitors on these measures - from left to right is the ThunderX Arm SoC from Cavium, Intel's microserver-targeted eight-core C2000 Atom processor and, in green, the X-Gene 2. On the far right is the Intel Xeon E5-2600 v2 processor, which while higher performing costs more. In the SPEC2006_rate processor benchmarks the X-Gene 2 delivers 55 percent better performance per watt than the X-Gene 1 and a 25 percent performance boost in ApacheBench web serving score. Compared to Intel servers the X-Gene will be competing against, Applied Micro claims the first generation chipset can deliver the performance of an Ivy Bridge or Haswell Xeon, while the X-Gene 2 will offer greater performance at lower power and be suited to latency-sensitive clustered applications. Applied Micro says a rack of X-Gene 2 systems will burn about 30 kilowatts and pack 6,480 threads running at 2.8 GHz. The cluster will provide 50 TB of memory and 48 TBps of memory bandwidth. It will handle 750 million transactions per second on the memcached test with 95 percent of the transactions coming in at under 40 milliseconds. A cluster of 80 two-socket machines based on Intel's Xeon E5-2630 v2 processors, with six cores and twelve threads per socket, delivers 1,920 threads and deliver around 400 million transactions per second on the same memcached test in the same power envelope of around 30 KW. These benchmarks are provided by Applied Micro, however, so need to be treated with the appropriate level of skepticism until verified. Intel said Applied Micro's performance estimates are impossible to verify as "no-one has ever seen X-Gene 1-based system benchmarked using industry standard applications" and indicated the Xeon setup used in the comparison could be weighted in the X-Gene's favour. Intel has its own range of energy sipping, less powerful SoCs aimed at the server market, the Avoton series in its Intel Atom family, and for its part Intel claims these are more power efficient. "X-Gene 1 is based on 40nm process and has 8 cores and roughly 35 - 40W TDP [which reflects the maximum power consumption of the machine]. For comparison, Atom C2000 (Avoton) has 8 cores as well with 20W TDP," said an Intel spokeswoman. "X-Gene is expected to have 35 -40 W TDP for 8 cores, node power 59W, vs 8-cores, 20W Avoton and 28-35W node power. Best case scenario for them - same performance for twice as power." By the time the X-Gene 2 hits productions servers Intel is also likely to have refreshed its server chip line-up with its Broadwell-EP and Broadwell-EX Xeon chips - further improving its performance per watt. X-Gene 3 will increase the core count to a maximum of 64, increase the clock speed to 3GHz and introduce 2nd generation RoCE. It will move the X-Gene to a 16nm manufacturing process, with FinFET transistors. Applied Micro say the X-Gene family will be able to be used for "pretty much anything that runs in the datacentre today". That includes hosting large-scale web sites and services; web search services such as data serving and harvesting; NoSQL data storage and retrieval; data analytics services such as information classification and filtering and extraction; and hosting and streaming of media. The X-Gene 2 will be suited to a wider range of cloud and HPC applications than its predecessor, due to its low-latency, inter-server data transfer enabled by Roce. The X-Gene one has already been demoed tackling HPC and other datacentre workloads when paired with Nvidia Tesla GPU K20 accelerators. The X-Gene/ Nvidia Tesla accelerator pairing is being used in servers from Cirrascale, E4 and Eurotech. Each server is designed to specialise in different workloads, the Cirrascale on HPC and enterprise workloads, while the E4 is focused on seismic, signal and image processing, as well as running jobs against big data sets using map-reduce. Due to ship in volume by the fourth quarter of 2014 System on a chip based around eight ARM Cortex A57 processor cores, clocked at above 2GHz. Each pair of processor cores share 48KB of L1 instruction and 32KB of L2 data cache, as well as 1MB of L2 cache - providing up to 4MB of L2 cache for the entire chip. A total 8MB of unified L3 cache is shared between the cores. Support for up to 128GB of DDR3 or DDR4 ECC memory as unbuffered DIMMs, registered DIMMS or SODIMMs. The chipset uses ARM's System Memory Management Unit that allows various hypervisors to keep guest operating systems in separate pools of RAM. The SoC, which is made using a 28nm process, also includes support for a wide range of data I/O, including an eight-lane PCI Express 3 controller, two 10 GB/s Ethernet connections and eight SATA 3 ports. It also has a dedicated 1GbE system management port (RGMII). A system control processor, an ARM Cortex A5-based chip, is used to control power, configure the system, initiate booting, and act as a service processor for system management functions. A cryptographic co-processor acts as a dedicated accelerator for encryption and decryption, as well as compression and decompression, algorithms. Accelerated algorithms are Advanced Encryption Standard, Elliptic Curve Cryptography, RSA, Secure Hash Algorithm, Zlib compression, Zlib decompression and True Hardware Random Number Generator. AMD is also working on a pin-compatible version of ARM and x86 chips - allowing them to plug into the same socket and be swapped out as needed. Based on comments from AMD, the technology site AnandTech has also estimated the eight-core variant could achieve a score of 80 in the SPECint_rate benchmark, a total of 10 per core. Power consumption is unconfirmed but Anandtech estimates a TDP of 25W. AMD expects the Opteron A1100 to be suited to handling workloads whose compute demands are light and where data needs to be rapidly shuttled on and off the processor. "For such workloads, processors like 'Seattle,' with smaller cores and caches, can deliver the equivalent performance as traditional server processors with large cores and caches, but using much less power and area," AMD said in a presentation at the Hot Chips conference. Possible uses could include LAMP stack web servers, as well as memcached and cold storage servers. Facebook has already experimented with using an ARM-based system as the basis of an OCP Open Vault storage array. Sean White, an engineer at AMD was also quoted at the Hot Chip conference in Cupertino as saying the company would consider customising the processor to meet specific industry needs. Intel has also recently expanded the options for large customers who want custom silicon. This year several other ARM-based system-on-a-chip (SoC) processors are planned to launch, designed to carry out a range of datacentre tasks - from handling server workloads, to running storage arrays and virtualised network functions. To meet these needs, ARM-based SoCs are in the works from various companies, including Broadcom, Cavium and Texas Instruments.
News Article | May 9, 2017
NEXCOM’s latest series of 1U network security appliances, NSA 3170, provides elastic performance for small and medium-sized businesses (SMBs) to impose security measures at their discretion. Featuring scalable computing performance, expandable network connectivity, and configurable connection performance, the NSA 3170 series can flexibly impose firewall, united threat management (UTM), intrusion detection/protection, and anti-virus protection that serves the security goals of SMB networks. The NSA 3170 series provides scalable computing performance with an extensive selection of Inter® Xeon®, Core™, Pentium®, and Celeron® processors. Available with up to four computing cores, a clock rate of 3.9 GHz and 4.2 GHz with Intel® Turbo Boost Technology, and 32 GB of DDR4 2400 ECC memory, the NSA 3170 series is capable of executing tight and/or moderate security policies and processing high-volume network traffic at blazing fast speeds. With the NSA 3170 series, SMBs can filter traffic flow and control network access based on packet type, connection state, and payload without stifling network traffic, thereby striking an efficient balance between network security and productivity. To support the implementation of network segmentation and segregation, the NSA 3170 series is complemented with a series of LAN modules to allow for LAN expansion. In addition to the default LAN configuration, there are different connection interfaces, connection speeds, and LAN counts that SMBs can choose from. For a network split into numerous subnets according to department functions, SMBs can configure a maximum of sixteen LAN ports onto NEXCOM's network security appliance, or gear the appliance with high-speed 10 GbE connections to satisfy the high throughput requirement of busy networks. About NEXCOM: Founded in 1992, NEXCOM integrates its capabilities and operates six global businesses, which are IoT Automation Solutions, Intelligent Digital Security, Internet of Things, Intelligent Platform & Services, Mobile Computing Solutions, and Network and Communication Solutions. NEXCOM serves its customers worldwide through its subsidiaries in five major industrial countries. Under the IoT megatrend, NEXCOM expands its offerings with solutions in emerging applications including IoT, robotics, connected cars, Industry 4.0, and industrial security.
News Article | May 11, 2017
This innovative physical infrastructure is able to fully enable extremely demanding networked application areas thus far only dreamed of, such as Networked High Definition Virtual Reality Angie Communications, the world’s largest telecoms startup with projects underway in USA and Europe, and its technology partners IgniteNet, Fibrolan and Elva-1, today announced the launch of the world’s fastest and most scalable Internet Service Provider, utilizing purpose-built and jointly developed technologies and solutions. Angie intends to deploy the same technological and design model in all its upcoming markets. This consortium of next-generation communications expert technology firms have pushed the barriers of telecommunications and technology to create a 5G Primed Infrastructure available to, and affordable for, the masses — be they residents or businesses of all sizes — spanning and scaling buildings, neighborhoods, cities, and nations. The consortium partners are pioneers with ground-breaking achievements under their belts in their respective fields. Their combined technological, engineering and R&D prowess has resulted in a unique scalable design and deployment model that may well be the end game for fiber-optic build-outs in neighborhoods as its combined average throughput could exceed 40 and even 80 Gbps and the aggregated capacity could exceed 400 or 800 Gbps — per square mile. Such throughput and capacity per square mile should be able to handle the future explosive usage of VR and other forms of Reality applications. This innovative infrastructure, organized for and with Angie Communications by the technology consortium over the last 6+ months, is able to fully enable extremely demanding networked application areas thus far only dreamed of, such as Networked High Definition Virtual Reality, Mixed Reality, and Augmented Reality. In essence, the Angie infrastructure is the “killer platform” for “killer initiatives” and “killer applications” such as Microsoft’s HoloLens, Facebook’s Oculus, and Google VR - Daydream, Cardboard, and Jump (VR film-making), Samsung Gear VR, TheWaveVR (a VR platform for music lovers), InstaVR, 8th Wall, and Mindshow. Simply put, thanks to the consortium’s customized and purpose-built technologies, Angie is the only firm in the world able to build VR, AR, and Mixed Reality capable infrastructure on a huge scale. Without Angie’s infrastructure, the dream of massive-scale Networked x-Reality will never be realized (due to limitations of current systems and networks). As stated before, Angie’s Wireless Extreme network is, among others, the killer platform for x-Reality – i.e., the future across any and all vertical sectors: Education/Learning, Design Prototyping, Gaming, Architecture & Interiors, Simulation, Virtual Worlds & Communities, Entertainment, Retail, etc. With the Networked Virtual Reality Platform more than capably addressed, it follows that other emerging — lesser demanding — 5G application platforms and areas such as Small Cell fiber backhaul, Smart Cities-As-A-Platform, IoT, and Connected-Everything, are also easily catered for from the same revolutionary infrastructure. Additional information is available through these breakthrough joint publications and announcements: Angie has Wired Extreme & Wireless Extreme infrastructure Hubs imminent and already live in multiple locations throughout the Netherlands, with more to follow closely in our other initial roll-out markets — UK and US. Some specifics on the Angie infrastructure, as devised with the technology partners: Angie was founded by an international team of highly qualified technology professionals. Angie’s team includes renowned visionaries and industry pioneers who have helped shape the 4G mobile, 5G wireless and Fibre-To-The Premises industries. Angie’s founding team has a combined 500+ years of experience in business; its executive team consists of industry pioneers and experts with a combined 300 years of telecom experience. Angie is proud Partner Sponsor of the Broadband World Forum in Berlin, 24-26 October, 2017, where the consortium partners will be present at Angie’s 100+ square meter information booth. Angie’s CEO will be a keynote speaker on October 25. For more information about Angie’s Gigabit Wireless Extreme projects, please visit www.angiewireless.com/news or watch the explainer video with NBA Hall of Fame legend and Angie angel investor Rick Barry, here. Headquartered in Irvine, CA, IgniteNet is a wholly owned subsidiary of SMC Networks, Inc. IgniteNet has a proven track record of producing powerful, reliable, easy-to-deploy, and innovative cloud managed wireless solutions and the industry's lowest-cost 60 GHz wireless technology through channel partners worldwide, focusing on Enterprises and Service Providers. For more information, please visit http://www.ignitenet.com. Founded in 1993, ELVA‐1 is world renowned in the commercial industrial and scientific instrumentation markets as a trusted supplier of components and systems for frequencies from 30 GHz to 1THz. Since 2000, ELVA‐1 has designed and manufactured ultra‐high speed radio links according to ECC and FCC requirements. Their available link operating frequencies include 40.5‐43.5 GHz, 71‐76 & 81‐86 GHz, and 92‐95 GHz with emphasis on 71‐76 & 81‐86 GHz as the FCC has streamlined licensing rules for E‐band. Similarly, the European CEPT channel plan regulations (ECC Recommendation(05)07) for 71‐76 GHz and 81-86 GHz frequency band radios has opened EU wireless fronthaul, backhaul and network extension markets for point‐to‐point fixed wireless systems (FWS). Founded in 1996, Fibrolan has broad experience in the development, production, delivery and long-term support of communication infrastructure systems. The company specializes in multiple key areas, such as Intelligent Access Networks, Timing and Synchronization and xWDM. These enable Fibrolan to deliver comprehensive solutions for a variety of applications and market verticals. One of the company’s most important assets is its ability to deliver optimized solutions to its customers (including dedicated development), in record time, thanks to its start-up attitude, combined with extensive and solid infrastructure and knowledge, based on more than 20 years of experience.
News Article | May 9, 2017
MUNICH, GERMANY and PALO ALTO, CA--(Marketwired - May 9, 2017) - Yubico, the leading provider of simple and open online identity protection, today announced the company's participation and activities at the European Identity & Cloud Conference 2017 (EIC), May 9-12, in Munich, Germany. At EIC, Yubico will be participating on a panel discussion, showcasing new YubiKey functionality, and demonstrating FIDO Universal 2nd Factor (U2F) authentication at booth #G04. The YubiKey secures access to a wide range of consumer and enterprise applications, all with a simple touch. A single YubiKey can perform authentication to U2F supported services (Facebook, Google, Dropbox, GitHub, Salesforce, etc.), password managers (LastPass, Dashlane, etc.), Windows login including Windows Hello, remote access, IAM, VPN, and much more. The YubiKey works on Microsoft Windows, Mac, Linux, and on major browsers without the need for extra software or drivers. Recently introduced to the market, the YubiKey 4C is the world's first multi-protocol USB-C authentication device. The YubiKey 4C contains the same proven firmware and functionality as the YubiKey 4. The YubiKey 4 series, which is now comprised of the original YubiKey 4, the YubiKey 4 Nano, and YubiKey 4C, all perform FIDO U2F, Yubico OTP, OATH, OpenPGP (up to RSA 4096), as well as PIV smart card (up to RSA 2048 and up to ECC P384). This new form factor is designed for laptops featuring only USB-C ports. Speaking Sessions Yubico's VP of Sales for Central Europe, Christian Reuter will be participating in the session 'Killing the Password Once Again: Will the strong authentication providers finally succeed? on Wednesday, May 10, 2:30-3:30 with panelists from Microsoft, OpenID Foundation, Atos Cybersecurity and KeyIdentity. The session will examine the topic of passwords as a weak form of authentication, the current industry and solution landscape, and if we are approaching the "password dawn". For more information and to learn more about YubiKeys and FIDO U2F, please visit www.yubico.com. About Yubico Yubico sets new world standards for simple, secure login, preventing unauthorized access to computers, servers, and internet accounts. Supporting multiple authentication and encryption protocols on all devices and platforms, YubiKeys protect access to user accounts for the world's largest enterprises with a simple touch, and with no driver or client software needed. Yubico is a leading contributor to the FIDO Universal 2nd Factor open authentication standard, and Yubico's technology is used, and loved, in more than 160 countries. Founded in 2007, Yubico is privately held with offices in Palo Alto (California), Seattle (Washington), and Stockholm (Sweden). For more information, please visit www.yubico.com.
News Article | May 10, 2017
"Considering the company's progress in the first quarter and year to date," commented Randal J. Kirk, Chairman and Chief Executive Officer of Intrexon, "I am gratified by the vision that underlies this company, by the business plan that has made it possible to do so much relative to such a modest expenditure of our shareholder's cash, by the confidence of our shareholders, our board and our team in that plan's ultimate feasibility and by the patience of all while our brilliant team would mature the company's technical assets and human capital into realizations that will make a great difference in the world." Mr. Kirk concluded, "We believe that we quite clearly have before us a number of significant realizations – in health, in energy, in food, in environment and in consumer industries – and we are fully engaged upon them." First Quarter 2017 Financial Results Compared to Prior Year Period Total revenues increased $10.3 million, or 24%, over the quarter ended March 31, 2016. Collaboration and licensing revenues increased $9.0 million from the quarter ended March 31, 2016 due to (i) the recognition of deferred revenue for upfront payments received from collaborations signed by the Company between April 1, 2016 and March 31, 2017 and the recognition of the payment received in June 2016 from ZIOPHARM to amend the collaborations between us; and (ii) increased research and development services for these collaborations and for the progression of programs or the addition of new programs with previously existing collaborators. Product revenues decreased $0.4 million, or 5% primarily due to a decrease in the quantities of pregnant cows sold due to lower customer demand for these products. Gross margin on products was consistent period over period. Service revenues increased $1.4 million, or 13%, due to an increase in the number of bovine in vitro fertilization cycles performed due to higher customer demand. Gross margin on services decreased slightly in the current period primarily due to an increase in royalties and commissions due to vendors. Research and development expenses increased $8.3 million, or 32%, due primarily to increases in (i) salaries, benefits and other personnel costs for research and development employees, (ii) lab supplies and consulting expenses, and (iii) depreciation and amortization. Salaries, benefits and other personnel costs increased $2.6 million due to an increase in research and development headcount to support new and expanded collaborations. Lab supplies and consulting expenses increased $3.4 million as a result of (i) the progression of certain programs into the preclinical and clinical phases with certain of Intrexon's collaborators, and (ii) the increased level of research and development services provided to Intrexon's collaborators. Depreciation and amortization increased $1.3 million primarily as a result of amortization of developed technology acquired from Oxitec Limited which began in November 2016 upon the completion of certain operational and regulatory events. Selling, general and administrative (SG&A) expenses decreased $7.7 million, or 18%. Salaries, benefits and other personnel costs decreased $4.9 million primarily due to the reversal of previously recognized stock-based compensation expense for stock options granted to a former employee. In 2016, the Company recorded $4.2 million in litigation expenses arising from the entrance of a court order in the Company's trial with XY, LLC. These SG&A decreases were offset by an increase of $2.1 million of legal and professional fees due to (i) expenses incurred to support domestic and international government affairs for regulatory and other approvals necessary to commercialize the Company's products and services; and (ii) increased legal fees to defend ongoing litigation. Total other income (expense), net, increased $24.8 million, or 116%, from the quarter ended March 31, 2016. This increase was primarily attributable to (i) a decline in unrealized depreciation in the Company's equity securities portfolio of $20.3 million, and (ii) dividend income of $3.9 million from the Company's investments in preferred stock. The Company will host a conference call today Wednesday, May 10th, at 4:30 PM ET to discuss the first quarter 2017 financial results and provide a general business update. The conference call may be accessed by dialing 1‑888-317-6003 (Domestic US), 1-866-284-3684 (Canada), and 1-412-317-6061 (International) and providing the number 0126057 to join the Intrexon Corporation Call. Participants may also access the live webcast through Intrexon's website in the Investors section at http://investors.dna.com/events. Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet. Intrexon's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn. This press release presents Adjusted EBITDA and Adjusted EBITDA per share, which are non-GAAP financial measures within the meaning of applicable rules and regulations of the Securities and Exchange Commission (SEC). For a reconciliation of these measures to the most directly comparable financial measure calculated in accordance with generally accepted accounting principles and for a discussion of the reasons why the company believes that these non-GAAP financial measures provide information that is useful to investors see the tables below under "Reconciliation of GAAP to Non-GAAP Measures." Such information is provided as additional information, not as an alternative to Intrexon's consolidated financial statements presented in accordance with GAAP, and is intended to enhance an overall understanding of the Intrexon's current financial performance. Intrexon, Friendly, RheoSwitch Therapeutic System, RTS, Powering the Bioindustrial Revolution with Better DNA, and Better DNA are trademarks of Intrexon and/or its affiliates. Other names may be trademarks of their respective owners. Some of the statements made in this press release are forward-looking statements that involve a number of risks and uncertainties and are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon Intrexon's current expectations and projections about future events and generally relate to Intrexon's plans, objectives and expectations for the development of Intrexon's business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release. These risks and uncertainties include, but are not limited to, (i) Intrexon's current and future ECCs and joint ventures; (ii) Intrexon's ability to successfully enter new markets or develop additional products, whether with its collaborators or independently; (iii) actual or anticipated variations in Intrexon's operating results; (iv) actual or anticipated fluctuations in Intrexon's competitors' or its collaborators' operating results or changes in their respective growth rates; (v) Intrexon's cash position; (vi) market conditions in Intrexon's industry; (vii) the volatility of Intrexon's stock price; (viii) Intrexon's ability, and the ability of its collaborators, to protect Intrexon's intellectual property and other proprietary rights and technologies; (ix) Intrexon's ability, and the ability of its collaborators, to adapt to changes in laws or regulations and policies; (x) the outcomes of pending or future litigation; (xi) the rate and degree of market acceptance of any products developed by a collaborator under an ECC or through a joint venture; (xii) Intrexon's ability to retain and recruit key personnel; (xiii) Intrexon's expectations related to the use of proceeds from its public offerings and other financing efforts; (xiv) Intrexon's estimates regarding expenses, future revenue, capital requirements and needs for additional financing; and (xv) Intrexon's expectations relating to its subsidiaries and other affiliates. For a discussion of other risks and uncertainties, and other important factors, any of which could cause Intrexon's actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in Intrexon's Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in Intrexon's subsequent filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and Intrexon undertakes no duty to update this information unless required by law. For more information regarding Intrexon Corporation, contact: Intrexon Corporation and Subsidiaries Reconciliation of GAAP to Non-GAAP Measures (Unaudited) Adjusted EBITDA and Adjusted EBITDA per share. To supplement Intrexon's financial information presented in accordance with U.S. generally accepted accounting principles ("GAAP"), Intrexon presents Adjusted EBITDA and Adjusted EBITDA per share. A reconciliation of Adjusted EBITDA to net income or loss attributable to Intrexon under GAAP appears below. Adjusted EBITDA is a non-GAAP financial measure that Intrexon calculates as net income or loss attributable to Intrexon adjusted for income tax expense or benefit, interest expense, depreciation and amortization, stock-based compensation, shares issued as compensation for services, bad debt expense, litigation expenses, realized and unrealized appreciation or depreciation in the fair value of equity securities and preferred stock, and equity in net loss of affiliates. Adjusted EBITDA and Adjusted EBITDA per share are key metrics for Intrexon's management and Board of Directors for evaluating the Company's financial and operating performance, generating future operating plans and making strategic decisions about the allocation of capital. Management and the Board of Directors believe that Adjusted EBITDA and Adjusted EBITDA per share are useful to understand the long-term performance of Intrexon's core business and facilitate comparisons of the Company's operating results over multiple reporting periods. Intrexon is providing this information to investors and others to assist them in understanding and evaluating the Company's operating results in a manner similar to how its management and Board of Directors evaluate operating results (except for the impact of the change in deferred revenue related to upfront and milestone payments, which is adjusted in the measures evaluated by management and the Board of Directors as discussed below). While Intrexon believes that its non-GAAP financial measures are useful in evaluating its business, and may be of use to investors, this information should be considered as supplemental in nature and is not meant as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as non-GAAP financial measures presented by other companies. Adjusted EBITDA and Adjusted EBITDA per share are not measures of financial performance under GAAP, and are not intended to represent cash flows from operations nor earnings per share under GAAP and should not be used as an alternative to net income or loss as an indicator of operating performance or to represent cash flows from operating, investing or financing activities as a measure of liquidity. Intrexon compensates for the limitations of Adjusted EBITDA and Adjusted EBITDA per share by using them only to supplement the Company's GAAP results to provide a more complete understanding of the factors and trends affecting the Company's business. Adjusted EBITDA and Adjusted EBITDA per share have limitations as an analytical tool and you should not consider them in isolation or as a substitute for analysis of Intrexon's results as reported under GAAP. In addition to the reasons stated above, which are generally applicable to each of the items Intrexon excludes from its non-GAAP financial measure, Intrexon believes it is appropriate to exclude certain items from the definition of Adjusted EBITDA for the following reasons: Furthermore, supplemental information about the impact of the change in deferred revenue related to upfront and milestone payments is provided below. GAAP requires Intrexon to account for its collaborations as multiple-element arrangements. As a result, the Company initially defers certain collaboration revenues because certain of its performance obligations cannot be separated and must be accounted for as one unit of accounting. The collaboration revenues that Intrexon so defers arise from upfront and milestone payments received from the Company's collaborators, which Intrexon recognizes over the future performance period even though the Company's right to such consideration is neither contingent on the results of Intrexon's future performance nor refundable in the event of nonperformance. The supplemental information about the change in deferred revenue removes the noncash revenue recognized during the period and includes the cash and stock received from collaborators for upfront and milestone payments during the period. Management and the Board of Directors consider this information in evaluating Intrexon's operating performance as they believe it permits the quarterly and annual comparisons of the Company's ability to consummate new collaborations or to achieve significant milestones with existing collaborators. The following table presents a reconciliation of net income (loss) attributable to Intrexon to EBITDA and also to Adjusted EBITDA, as well as the calculation of Adjusted EBITDA per share, for each of the periods indicated: To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/intrexon-announces-first-quarter-2017-financial-results-300455486.html